These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3969234)

  • 1. Discordant human chorionic gonadotropin results: causes and solutions.
    Hussa RO; Rinke ML; Schweitzer PG
    Obstet Gynecol; 1985 Feb; 65(2):211-9. PubMed ID: 3969234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.
    Boyko WL; Russell HT
    Obstet Gynecol; 1979 Dec; 54(6):737-45. PubMed ID: 514561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ; Buck RH; Joubert SM
    S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors.
    Harvey RA; Mitchell HD; Stenman UH; Blankenstein MA; Nustad K; Stieber P; Stewart W; Savage PM; Seckl MJ; Braunstein GD
    J Reprod Med; 2010; 55(7-8):285-95. PubMed ID: 20795340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK; Gokel JM; Holzmann K
    Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract]   [Full Text] [Related]  

  • 8. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy.
    Steier JA; Bergsjø P; Myking OL
    Obstet Gynecol; 1984 Sep; 64(3):391-4. PubMed ID: 6462569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of pregnancy by the radioreceptorassay of human chorionic gonadotropin.
    Saxena BB; Landesman R
    Am J Obstet Gynecol; 1978 May; 131(1):97-107. PubMed ID: 347938
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of hCG serum levels in choriocarcinoma using monoclonal antibodies].
    Vlachová J; Zavadil M; Jakoubková J; Skrivan J; Minajev G
    Cesk Gynekol; 1989 Apr; 54(3):179-84. PubMed ID: 2766368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours.
    Evans BD; Harvey VJ; Knox BS; Duff G
    N Z Med J; 1993 Jun; 106(958):261. PubMed ID: 8392672
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.